CENT vs SGRY
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
CENT · Central Garden & Pet$47.78 ▼ 0.33%
SGRY · Surgery Partners$23.20 ▲ 0.13%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- CENT +50.4%
- SGRY +44.7%
Head to head
| Metric | CENT | SGRY |
|---|---|---|
| Price | $47.78 | $23.20 |
| Change today | ▼ 0.33% | ▲ 0.13% |
| Market cap | $2.99B | $2.99B |
| Return, 3 months | +8.8% | +45.5% |
| Return, year to date | +48.6% | +50.2% |
| Return, 1 year | +52.1% | +7.9% |
| P/E (TTM) | 17.7 | -33.6 |
| P/B | 1.7 | 1.8 |
| P/E percentile vs own 5y | 51st | 61st |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | -8.2% | +2.7% |
| Net profit growth (YoY) | -5.7% | -33.9% |
| Gross margin | 32.5% | 22.5% |
| Operating margin | 8.1% | 13.7% |
| Net margin | 5.4% | -2.6% |
| Return on equity | 10.0% | -5.2% |
| Analyst target vs. price | +3.6% | -10.0% |
| Analyst buy share | 50% | 22% |
| RSI (14) | 72 | 85 |
| 30-day volatility | 25.9% | 116.1% |
| Max drawdown, 1 year | -16.4% | -49.9% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Hold | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- CENT is the largest of the group by market value.
- CENT has returned the most over the past year.
- SGRY carries the lowest trailing P/E.
- SGRY is growing revenue fastest.
- CENT keeps the most profit per dollar of sales.
- CENT has been the calmest stock over the last 30 days.